You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Minimizing Disparities in Breast Cancer to Enhance Equitable Cancer Care

  • Authors: Erica Stringer-Reasor, MD; Allison R. Butts, PharmD, BCOP; Karen Drucker, NP, RN; Toni Willis, MD
  • CME / ABIM MOC / CE Released: 3/13/2023
  • Valid for credit through: 3/13/2024, 11:59 PM EST
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    Nurses - 0.50 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    Pharmacists - 0.50 Knowledge-based ACPE (0.050 CEUs)

    IPCE - 0.50 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for oncologists, nurses, and pharmacists.

The goal of this activity is for learners to be better able to appreciate breast cancer disparities and their multifactorial etiologies and to provide strategies and resources for clinicians to proactively mitigate barriers that lead to disparities in patient outcomes.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Evidence on disparities in breast cancer
    • Impact of disparities on breast cancer outcomes
    • Strategies to improve the outcomes of breast cancer care for underserved and vulnerable populations
  • Demonstrate greater confidence in their
    • Understanding of the roles of different members of the interprofessional team in mitigating breast cancer disparities


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Moderator

  • Erica Stringer-Reasor, MD

    Associate Professor of Medicine
    Division of Hematology and Oncology
    Director of the Breast Cancer Program
    University of Alabama at Birmingham
    O'Neal Comprehensive Cancer Center
    Birmingham, Alabama

    Disclosures

    Erica Stringer-Reasor, MD, has the following relevant financial relationships: 
    Consultant or advisor for: AstraZeneca; Immunomedics, Inc.; Lilly; Merck; Novartis; Seagen, Inc. 
    Speaker or member of speakers bureau for: Lilly

Faculty

  • Allison R. Butts, PharmD, BCOP

    Oncology Clinical Pharmacist Manger
    Breast Oncology Clinical Specialist
    UK Healthcare Markey Cancer Center
    Associate Professor
    Pharmacy Practice and Science Department
    University of Kentucky College of Pharmacy
    Lexington, Kentucky

    Disclosures

    Allison R. Butts, PharmD, BCOP, has the following relevant financial relationships: 
    Consultant or advisor for: AstraZeneca; BeyondSpring Pharmaceuticals

  • Karen Drucker, NP, RN

    Nurse Practitioner
    Breast Medicine
    Memorial Sloan-Kettering Cancer Center
    New York, New York

    Disclosures

    Karen Drucker, NP, RN, has no relevant financial relationships.

Patient Advocate

  • Toni Willis, MD

    Physical Medicine and Rehabilitation Specialist
    2022 LBBC Hear My Voice Advocate
    Dallas, Texas

    Disclosures

    Toni Willis, MD, has no relevant financial relationships.

Editors

  • Davecia Ragoonath-Cameron, MS

    Medical Education Director, Medscape, LLC

    Disclosures

    Davecia R. Cameron, MS, has no relevant financial relationships.

  • Christin Melton, ELS

    Associate Medical Education Director, Medscape, LLC 

    Disclosures

    Christin Melton, ELS, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.


Accreditation Statements

Developed through a strategic collaboration between Living Beyond Breast Cancer and Medscape Oncology.

Medscape

Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

IPCE

This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) (Universal Activity Number: JA0007105-0000-23-101-H01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Minimizing Disparities in Breast Cancer to Enhance Equitable Cancer Care

Authors: Erica Stringer-Reasor, MD; Allison R. Butts, PharmD, BCOP; Karen Drucker, NP, RN; Toni Willis, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 3/13/2023

Valid for credit through: 3/13/2024, 11:59 PM EST

processing....

  • Print